Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 1, 2010, Pages 273-280

  Adner, Mikael ^a   Larsson, Bengt ^b   Säfholm, Jesper ^a   Naya, Ian ^c   Miller Larsson, Anna ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; CARBACHOL; CYCLIC AMP; CYCLOOXYGENASE 2; FORMOTEROL; INTERLEUKIN 1BETA; MESSENGER RNA; SALMETEROL; TERBUTALINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DESENSITIZATION; DISEASE EXACERBATION; GENE EXPRESSION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SMOOTH MUSCLE RELAXATION; TRACHEA; TREATMENT RESPONSE;

ALBUTEROL; ANIMALS; BRONCHODILATOR AGENTS; BUDESONIDE; CYCLIC AMP; CYCLOOXYGENASE 2; CYTOKINES; DRUG INTERACTIONS; GLUCOCORTICOIDS; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED BALB C; MUSCLE RELAXATION; MUSCLE, SMOOTH; ORGAN CULTURE TECHNIQUES; RECEPTORS, ADRENERGIC, BETA-2; TERBUTALINE; TRACHEA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949676634     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.156224     Document Type: Article

References (32)

1. Adner M, Rose AC, Zhang Y, Swärd K, Benson M, Uddman R, Shankley NP, and Cardell LO (2002) An assay to evaluate the long-term effects of inflammatory mediators on murine airway smooth muscle: evidence that TNFalpha up-regulates 5-HT(2A)-mediated contraction. Br J Pharmacol 137:971-982.
2. Anderson GP (2000) Interactions between corticosteroids and beta-adrenergic agonists in asthma disease induction, progression, and exacerbation. Am J Respir Crit Care Med 161:S188-S196.
3. Bachar O, Rose AC, Adner M, Wang X, Prendergast CE, Kempf A, Shankley NP, and Cardell LO (2005) TNF alpha reduces tachykinin, PGE2-dependent, relaxation of the cultured mouse trachea by increasing the activity of COX-2. Br J Pharmacol 144:220-230.
4. Bai TR (1990) Abnormalities in airway smooth muscle in fatal asthma. Am Rev Respir Dis 141:552-557.
5. Baraniuk JN, Ali M, Brody D, Maniscalco J, Gaumond E, Fitzgerald T, Wong G, Yuta A, Mak JC, Barnes PJ, et al. (1997) Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa. Am J Respir Crit Care Med 155:704-710.
6. Barnes PJ and Pride NB (1983) Dose-response curves to inhaled beta-adrenoceptor agonists in normal and asthmatic subjects. Br J Clin Pharmacol 15:677-682.
7. Broide DH, Lotz M, Cuomo AJ, Coburn DA, Federman EC, and Wasserman SI (1992) Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 89:958-967.
8. Daaka Y, Luttrell LM, and Lefkowitz RJ (1997) Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390:88-91.
9. Hakonarson H, Herrick DJ, Serrano PG, and Grunstein MM (1996) Mechanism of cytokine-induced modulation of beta-adrenoceptor responsiveness in airway smooth muscle. J Clin Invest 97:2593-2600.
10. Hirata F, Lee JY, Sakamoto T, Nomura A, Uchida Y, Hirata A, and Hasegawa S (1994) IL-1 beta regulates the expression of the Gi2 alpha gene via lipid mediators in guinea pig tracheal muscle. Biochem Biophys Res Commun 203:1889-1896.
11. Jaeschke R, O'Byrne PM, Mejza F, Nair P, Lesniak W, Brozek J, Thabane L, Cheng J, Schünemann HJ, Sears MR, et al. (2008) The safety of long-acting beta-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis. Am J Respir Crit Care Med 178:1009-1016.
12. Kalavantavanich K and Schramm CM (2000) Dexamethasone potentiates high-affinity beta-agonist binding and g(s)alpha protein expression in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 278:L1101-L1106.
13. Källström BL, Sjöberg J, and Waldeck B (1994) The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro. Br J Pharmacol 113:687-692.
14. Kenakin T (1997) Pharmacologic Analysis of Drug-Receptor Interaction, Lippincott Williams & Wilkins, Baltimore, MD.
15. Koto H, Mak JC, Haddad EB, Xu WB, Salmon M, Barnes PJ, and Chung KF (1996) Mechanisms of impaired beta-adrenoceptor-induced airway relaxation by interleukin-1beta in vivo in the rat. J Clin Invest 98:1780-1787.
16. Kuna P, Peters MJ, Manjra AI, Jorup C, Naya IP, Martínez-Jimenez NE, and Buhl R (2007) Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations. Int J Clin Pract 61:725-736.
17. Lee RT, Brock TA, Tolman C, Bloch KD, Seidman JG, and Neer EJ (1989) Subtype-specific increase in G-protein alpha-subunit mRNA by interleukin 1 beta. FEBS Lett 249:139-142.
18. Mak JC, Hisada T, Salmon M, Barnes PJ, and Chung KF (2002) Glucocorticoids reverse IL-1beta-induced impairment of beta-adrenoceptor- mediated relaxation and up-regulation of G-protein-coupled receptor kinases. Br J Pharmacol 135:987-996.
19. Mak JC, Nishikawa M, and Barnes PJ (1995) Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung. Am J Physiol 268:L41-L46.
20. McGraw DW, Elwing JM, Fogel KM, Wang WC, Glinka CB, Mihlbachler KA, Rothenberg ME, and Liggett SB (2007) Crosstalk between Gi and Gq/Gs pathways in airway smooth muscle regulates bronchial contractility and relaxation. J Clin Invest 117:1391-1398.
21. McGrawDWand Liggett SB (2005) Molecular mechanisms of beta2-adrenergic receptor function and regulation. Proc Am Thorac Soc 2:292-296, discussion 311-312.
22. Molimard M, Naline E, Zhang Y, Le Gros V, Begaud B, and Advenier C (1998) Longand short-acting beta2 adrenoceptor agonists: interactions in human contracted bronchi. Eur Respir J 11:583-588.
23. O'Byrne PM, Barnes PJ, Rodriguez-Roisin R, Runnerstrom E, Sandstrom T, Svensson K, and Tattersfield A (2001) Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial. Am J Respir Crit Care Med 164:1392-1397.
24. O'Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, Ekström T, and Bateman ED (2005) Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 171:129-136.
25. Pauwels RA, Löfdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, and Ullman A (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337:1405-1411.
26. Pönicke K, Gröner F, Heinroth-Hoffmann I, and Brodde OE (2006) Agonist-specific activation of the beta2-adrenoceptor/Gs-protein and beta2-adrenoceptor/Gi-protein pathway in adult rat ventricular cardiomyocytes. Br J Pharmacol 147:714-719.
27. Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, and Lalloo UG (2006) Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet 368:744-753.
28. Shore SA, Laporte J, Hall IP, Hardy E, and Panettieri RA Jr (1997) Effect of IL-1 beta on responses of cultured human airway smooth muscle cells to bronchodilator agonists. Am J Respir Cell Mol Biol 16:702-712.
29. Shore SA and Moore PE (2003) Regulation of beta-adrenergic responses in airway smooth muscle. Respir Physiol Neurobiol 137:179-195.
30. Stern L and Kunos G (1988) Synergistic regulation of pulmonary beta-adrenergic receptors by glucocorticoids and interleukin-1. J Biol Chem 263:15876-15879.
31. Tonnel AB, Gosset P, and Tillie-Leblond I (2001) Characteristics of the Inflammatory response in bronchial lavage fluids from patients with status asthmaticus. Int Arch Allergy Immunol 124:267-271.
32. Wills-Karp M, Uchida Y, Lee JY, Jinot J, Hirata A, and Hirata F (1993) Organ culture with proinflammatory cytokines reproduces impairment of the betaadrenoceptor-mediated relaxation in tracheas of a guinea pig antigen model. Am J Respir Cell Mol Biol 8:153-159.